A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

---

Icli F., ÇELİK İ., Aykan F., Uner A., DEMİRKAZIK A., Ozet A., ...More

CANCER, vol.83, no.12, pp.2475-2480, 1998 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 83 Issue: 12
• Publication Date: 1998
• Journal Name: CANCER
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.2475-2480
• Keywords: advanced gastric carcinoma, cisplatin, epirubicin, etoposide, 5-fluorouracil, randomized controlled trial, CANCER, DOXORUBICIN, COMBINATION, FLUOROURACIL, CHEMOTHERAPY, ADRIAMYCIN, MITOMYCIN, REGIMENS, CELLS
• Lokman Hekim University Affiliated: No

Abstract

BACKGROUND, Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with advanced gastric carcinoma (AGC)